Sanzyme Biologics
Dhruv Soman is an accomplished Executive Director at Sanzyme Biologics, where since July 2013, responsibilities include the commercialization of proprietary strains like Bacillus coagulans SNZ 1969 across more than 35 countries and acting as a research and manufacturing partner for biotechnology and probiotics. Previously, as Manager of New Projects at Sanzyme from November 2009 to April 2011, Dhruv Soman identified diversification opportunities based on in-house R&D capabilities and collaborated with senior management and sales teams to assess market demand. Educational credentials include an MBA in Entrepreneurship from Babson F.W. Olin Graduate School of Business and a Bachelor of Commerce in Banking and Insurance from HR College of Commerce and Economics, Mumbai.
This person is not in any teams
This person is not in any offices
Sanzyme Biologics
1 followers
Sanzyme Biologics is a biotechnology company specializing in the fermentation. It produces, markets, and sells proprietary probiotic strains, its flagship strain being SNZ 1969 Bacillus Coagulans (used in Sporlac). It’s aquaculture division (Kenko) directly markets its solutions to export based aquaculture farmers across India. The poultry division (Sanco) works with established market players to develop probiotics for feed / feed additive companies. Sanzyme Biologics is a sister company to Sanzyme Pvt Ltd (https://www.linkedin.com/company/2957632/)